Literature DB >> 7060033

Rationale for the use of alternating non-cross-resistant chemotherapy.

J H Goldie, A J Coldman, G A Gudauskas.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7060033

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  78 in total

1.  [Sequential induction chemotherapy and radiation treatment of inoperable small cell bronchial cancer. Results of a prospective randomized study].

Authors:  J Schütte; N Niederle; W Eberhardt; S Seeber; W Alberti; V Budach; H Hirche; C G Schmidt
Journal:  Klin Wochenschr       Date:  1989-12-04

2.  A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance.

Authors:  S Michelson; D Slate
Journal:  Bull Math Biol       Date:  1992-11       Impact factor: 1.758

Review 3.  Drug resistance in oncology: from concepts to applications.

Authors:  J L Cazin; P Gosselin; P Cappelaere; J Robert; A Demaille
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling.

Authors:  E A Gaffney
Journal:  J Math Biol       Date:  2003-10-27       Impact factor: 2.259

Review 5.  The concept of dose intensification in the treatment of neoplastic disease.

Authors:  U B Wandl; N Niederle
Journal:  Infection       Date:  1992       Impact factor: 3.553

6.  An elementary approach to modeling drug resistance in cancer.

Authors:  Cristian Tomasetti; Doron Levy
Journal:  Math Biosci Eng       Date:  2010-10       Impact factor: 2.080

7.  Dynamics of targeted cancer therapy.

Authors:  Ivana Bozic; Benjamin Allen; Martin A Nowak
Journal:  Trends Mol Med       Date:  2012-05-15       Impact factor: 11.951

Review 8.  Modeling Tumor Clonal Evolution for Drug Combinations Design.

Authors:  Boyang Zhao; Michael T Hemann; Douglas A Lauffenburger
Journal:  Trends Cancer       Date:  2016-03

9.  The impact of cell density and mutations in a model of multidrug resistance in solid tumors.

Authors:  James Greene; Orit Lavi; Michael M Gottesman; Doron Levy
Journal:  Bull Math Biol       Date:  2014-02-20       Impact factor: 1.758

Review 10.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.